• 2012

Company Description

A biopharmaceutical company developing novel, localized therapeutics for the treatment of diseases caused by HPV infection.

Antiva Biosciences, Inc. is a biopharmaceutical company developing novel, localized therapeutics for the treatment of diseases caused by HPV infection. The company was founded as Hera Therapeutics in 2012 by Dr. Karl Hostetler at The University of California San Diego. We are now Antiva Biosciences, Inc., headquartered in South San Francisco.